Inspire Medical Systems Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
INSP$64.33+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations and Comprehensive Loss
Consolidated Statements of Operations and Comprehensive Loss (unaudited)
(in thousands, except share and per share amounts)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenue | $164,010 | $127,897 |
| Cost of goods sold | 24,757 | 19,888 |
| Gross profit | 139,253 | 108,009 |
| Operating expenses: | ||
| Research and development | 28,850 | 25,519 |
| Selling, general and administrative | 125,621 | 101,988 |
| Total operating expenses | 154,471 | 127,507 |
| Operating loss | (15,218) | (19,498) |
| Other (income) expense: | ||
| Interest and dividend income | (5,923) | (4,273) |
| Other expense (income), net | 60 | (17) |
| Total other income | (5,863) | (4,290) |
| Loss before income taxes | (9,355) | (15,208) |
| Income taxes | 650 | 216 |
| Net loss | (10,005) | (15,424) |
| Other comprehensive loss: | ||
| Foreign currency translation (loss) gain | (134) | 105 |
| Unrealized (loss) gain on investments | (542) | 13 |
| Total comprehensive loss | $(10,681) | $(15,306) |
| Net loss per share, basic and diluted | $(0.34) | $(0.53) |
| Weighted average common shares used to compute net loss per share, basic and diluted | 29,615,166 | 29,089,950 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.